EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Small-Molecule Antibiotic Drug Development: Need and Challenges

Megan Bergkessel, Barbara Forte iD, Ian H Gilbert iD

ACS Infectious Diseases · 10.11.2023 · 9 (11) · 2062-2071

DOI: 10.1021/acsinfecdis.3c00189 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, online erschienen am 11.10.2023. Verfasst von Megan Bergkessel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacterial Infections. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The need for new antibiotics is urgent. Antimicrobial resistance is rising, although currently, many more people die from drug-sensitive bacterial infections. The continued evolution of drug resistance is inevitable, fueled by pathogen population size and exposure to antibiotics. Additionally, opportunistic pathogens will always pose a threat to vulnerable patients whose immune systems cannot efficiently fight them even if they are sensitive to available antibiotics, according to clinical microbiology tests. These problems are intertwined and will worsen as human populations age, increase in density, and experience disruptions such as war, extreme weather events, or declines in standard of living. The development of appropriate drugs to treat all the world's bacterial infections should be a priority, and future success will likely require combinations of multiple approaches. However, the highest burden of bacterial infection is in Low- and Middle-Income Countries, where limited medical infrastructure is a major challenge. For effectively managing infections in these contexts, small-molecule-based treatments offer significant advantages. Unfortunately, support for ongoing small-molecule antibiotic discovery has recently suffered from significant challenges related both to the scientific difficulties in treating bacterial infections and to market barriers. Nevertheless, small-molecule antibiotics remain essential and irreplaceable tools for fighting infections, and efforts to develop novel and improved versions deserve ongoing investment. Here, we first describe the global historical context of antibiotic treatment and then highlight some of the challenges surrounding small-molecule development and potential solutions. Many of these challenges are likely to be common to all modalities of antibacterial treatment and should be addressed directly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacterial InfectionsHumans

Stichwörter der Autor:innen

antibiotic drug discoveryantibiotic toleranceantimicrobial resistancesmall-molecule antibiotic

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
  • Drug Discovery Unit and Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee DD1 5EH, U.K.

ORCID-Profile: Barbara Forte, Ian H Gilbert

Förderung

  • Wellcome Trust
  • Medical Research Council
  • British Heart Foundation
  • Department for Business, Energy and Industrial Strategy, UK Government
  • Diabetes UK
  • Academy of Medical Sciences

Zitieren

APA

Bergkessel, M., Forte, B., & Gilbert, I. H. (2023). Small-Molecule Antibiotic Drug Development: Need and Challenges. ACS Infectious Diseases, 9(11), 2062-2071. https://doi.org/10.1021/acsinfecdis.3c00189

Vancouver

Bergkessel M, Forte B, Gilbert IH. Small-Molecule Antibiotic Drug Development: Need and Challenges. ACS Infectious Diseases. 2023;9(11):2062-2071. doi:10.1021/acsinfecdis.3c00189

BibTeX
@article{Bergkessel2023,
  author = {Bergkessel, Megan and Forte, Barbara and Gilbert, Ian H},
  title = {Small-Molecule Antibiotic Drug Development: Need and Challenges},
  journal = {ACS Infectious Diseases},
  year = {2023},
  volume = {9},
  number = {11},
  pages = {2062--2071},
  doi = {10.1021/acsinfecdis.3c00189}
}
Kostenlos starten →